IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. N6‑methyladenosine (m6A) plays an important role in posttranscriptional gene regulation. METTL3 and IGF2BP2 are key genes in the m6A signal pathway and have recently been shown to play important roles in cancer development and progression. In our work, higher METTL3 and IGF2BP2 expression were found in HCC tissues and were associated with a poor prognosis. In addition, IGF2BP2 overexpression promoted HCC proliferation in vitro and in vivo. Mechanistically, IGF2BP2 directly recognized and bound to the m6A site on FEN1 mRNA and enhanced FEN1 mRNA stability. Overall, our study revealed that METTL3 and IGF2BP2, acting as an oncogene, maintained FEN1 expression through an m6A-IGF2BP2-dependent mechanism in HCC cells, and indicated a potential biomarker panel for prognostic prediction in liver Cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849 · cited 1×
“php) (16), we also found that patients with HCC with increased METTL3 and IGF2BP2 mRNA levels had worse overall survival (OS) (Figure 1B) (the group cutoff was set as quartile [cutoff-high (%) was 75% and cutoff-low (%) was 25%)].”
BackgroundRecognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997 · cited 3×
“Therefore, better prognostic indicators are needed to identify patients with poor prognosis and intervene as early as possible. m6A, the most abundant post-transcriptional modification, is mainly regulated by m6A WERs (“writers”, “erasers,” and “readers”) in diverse cell types (23, 24). m6A can affect the stability of…”
BackgroundMethodInfluentialRNA m6A modification and its function in diseases
Tong, J., Flavell, R. A., & Li, H.-B. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0654-8 · Cited by 233
Research works printed but not linked: 29
- International, 2018, Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies, BioMed Res Int, 2018, 10.1155/2018/4560161 · doi:10.1155/2018/4560161
- Syed, 2020, Ramucirumab: A Review in Hepatocellular Carcinoma, Drugs, 80, 10.1007/s40265-020-01263-6 · DOI
- Yang, 2018, Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism, Cell Res, 28, 10.1038/s41422-018-0040-8 · DOI · Paper page
- Zlotorynski, 2015, RNA metabolism: m6A modulates RNA structure, Nat Rev Mol Cell Biol, 16, 10.1038/nrm3974 · doi:10.1038/nrm3974
- Taketo, 2017, The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells, Int J Oncol, 52, 10.3892/ijo.2017.4219 · DOI · Paper page
- Balacco, 2018, The m6A writer: Rise of a machine for growing tasks, Biochemistry, 58, 10.1021/acs.biochem.8b01166 · DOI · Paper page
- Deng, 2020, Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma, Front Mol Bioences, 7, 10.3389/fmolb.2020.00068 · DOI · Paper page
- Li, 2018, Author Correction: Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion, Cell Res, 28, 1042, 10.1038/s41422-018-0083-x · doi:10.1038/s41422-018-0083-x
- Dai, 2018, N6-methyladenosine links RNA metabolism to cancer progression, Cell Death Disease, 9, 124, 10.1038/s41419-017-0129-x · DOI · Paper page
- Wang, 2017, Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers, Cancer Lett, 10.1016/j.canlet.2017.08.030 · DOI · Paper page
- Chao, 2019, Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China, Cancer Commun, 39, 42, 10.1186/s40880-019-0388-2 · DOI
- Hu, 2017, MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells, Autophagy, 13, 10.1080/15548627.2016.1256520 · DOI
- Tong, 2018, Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells, Cancer Commun, 38, 56, 10.1186/s40880-018-0326-8 · DOI
- Cardenas, 2009, Induction of apoptosis in vitro and in vivo effects of a synthetic nitroflavone derivative on murine mammary adenocarcinoma cells, Cancer Res, 69, 2145, 10.1158/0008-5472.SABCS-2145 · doi:10.1158/0008-5472.sabcs-2145
- Tomczak, 2015, The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge, Contemp Oncol, 19, A68, 10.5114/wo.2014.47136 · DOI · Paper page
- Chen, 2018, RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2, Hepatol Off J Am Assoc Study Liver Dis, 67, 10.1002/hep.29683 · DOI · Paper page
- Du, 2012, Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification, J Hum Genet, 57, 10.1038/jhg.2012.66 · DOI
- Xin, 2003, Molecular pathogenesis of human hepatocellular carcinoma, Toxicology, 10.1038/ng0802-339 · DOI · Paper page
- Mortezaee, 2018, Human hepatocellular carcinoma: Protection by melatonin, J Cell Physiol, 233, 10.1002/jcp.26586 · DOI · Paper page
- Qin, 2004, Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature, J Cancer Res Clin Oncol, 130, 497, 10.1007/s00432-004-0572-9 · DOI · Paper page
- Zhang, 2019, A Review in Research Progress Concerning m6A Methylation and Immunoregulation, Front Immunol, 10, 10.3389/fimmu.2019.00922 · DOI · Paper page
- Years, 2017, Rethinking m6A Readers, Writers, and Erasers, Annu Rev Cell Dev Biol, 33, 319, 10.1146/annurev-cellbio-100616-060758 · DOI · Paper page
- Zhou, 2019, Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database, Aging, 10.18632/aging.101856 · DOI · Paper page
- Zhu, 2020, An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis, Nat Commun, 11, 1685, 10.1038/s41467-020-15403-9 · DOI · Paper page
- Liu, 2020, The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression, Biomed Pharmacother, 127, 110098, 10.1016/j.biopha.2020.110098 · DOI
- Zaher, 2018, Missed cleavage opportunities by FEN1 lead to Okazaki fragment maturation via the long-flap pathway, Nucleic Acids Res, 6, 6, 10.1093/nar/gky082 · DOI
- He, 2017, FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer, Mol Oncol, 10.1002/1878-0261.12058 · DOI
- Chen, 2014, Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression, J Steroid Biochem Mol Biol, 143, 10.1016/j.jsbmb.2014.01.009 · DOI
- Li, 2011, Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer, Carcinogenesis, 1, 1, 10.1093/carcin/bgr250 · DOI
Cited by
Lin, Z., Lv, D., Liao, X., Peng, R., Liu, H., Wu, T., Wu, K., Sun, Y., & Zhang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226962 · Cited by 39
Zhou, L., Li, H., Cai, H., Liu, W., Pan, E., Yu, D., & He, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.809589 · Cited by 24
“New evidence shows that IGF2BP2 is an m6A-binding protein that promotes mRNA (for example, MYC) stability and translation in an m6A-dependent manner and participates in the development and progression of several malignant cancers (10, 11).”
BackgroundResultWu, T., Liao, L., Wu, T., Chen, S., Yi, Q., & Xu, M. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2283328 · Cited by 20
Chanda, S., Lepikhov, K., Dahlem, C., Schymik, H. S., Hoppstädter, J., Geber, A.-K., Wagner, K., Kessler, S. M., Empting, M., & Kiemer, A. K. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2901041 · Cited by 8
IMPlications of IMP2 in RNA Biology and Disease
Das, J., Busia-Bourdain, O., Khan, K. M., & Wolfe, A. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062415 · Cited by 3
Metadata
- Authors
- Pu, J., Wang, J., Qin, Z., Wang, A., Zhang, Y., Wu, X., Wu, Y., Li, W., Xu, Z., Lu, Y., Tang, Q., & Wei, H.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-02
- Volume
- 10
- Pages
- 578816-578816
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3096480398
- Cited by
- 156
- References
- 3
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Scientific Research and Technology Development Program of Guangxi
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism. https://app.cochat.ai/papers/10.3389/fonc.2020.578816
- The paper
- Pu, J., Wang, J., Qin, Z., Wang, A., Zhang, Y., Wu, X., Wu, Y., Li, W., Xu, Z., Lu, Y., Tang, Q., & Wei, H. (2020). IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism. Frontiers in Oncology. https://doi.org/10.3389/fonc.2020.578816
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.